Evidence map›Paper›PMID 28687213›Full record

ReviewInfectious disease clinics of North America2017

Prevention of Central Line-Associated Bloodstream Infections.

Taison Bell, Naomi P O'Grady

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Infectious disease clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. ECO-SEOM-SEEO safety recommendations guideline for cancer patients receiving intravenous therapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Guideline
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Taison BellCritical Care Medicine Department, National Institutes of Health, 10 Center Drive, Room 2C145, Bethesda, MD 20892-1662, USA. Electronic address: taison.bell@nih.gov.
Naomi P O'GradyCritical Care Medicine Department, National Institutes of Health, 10 Center Drive, Room 2C145, Bethesda, MD 20892-1662, USA.

Funding

Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

Central venous catheters (CVCs) are commonly used in critically ill patients and offer several advantages to peripheral intravenous access. However, indwelling CVCs have the potential to lead to bloodstream infections, with the risk increasing with an array of characteristics, such as catheter choice, catheter location, insertion technique, and catheter maintenance. Evidence-based guidelines have led to a significant reduction in the incidence of bloodstream infections associated with CVCs. The combination of guideline implementation and newer technologies has the potential to further reduce morbidity and mortality from infections related to CVCs.

Indexed as

BacteremiaCatheterization, Central VenousCatheter-Related InfectionsCatheters, IndwellingCentral Venous CathetersCross InfectionHumansIncidenceIntensive Care UnitsBlood stream infectionCentral lineCentral venous catheterCLABSICRBSI

Identifiers

PMID28687213
PMCPMC5666696

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.